Hello Share Swappers. Medical companies have a favourable spot in my humble musings on possible share success. Today’s choice for your further perusal is Ergomed (ERGO). This is a niche company, another reason for me to favour it.
Hello, Share Troopers. Ergomed (ERGO) is an AIM company which does something fashionable these days. It helps makes sure that medical drugs and remedies pass the required tests to come on the market. It also monitors pharmaceutical products once they’re in circulation. It’s not just Covid vaccines that need investigation, of course. Many more drug trials are taking place all the time.
Ergomed (ERGO) receives a "buy" recommendation is the headline of the RNS Reach that has just gone out. It is very unusual to announce a broker report so I had a butchers at the RNS Reach - a Reach is an announcement the Nomad deems not to be price sensitive. Read on and you see why.